PARP Inhibitor

Advertisement
Rob DillardOncology | August 17, 2020
The findings of an international clinical trial found that men with advanced prostate cancer who have mutated ...
Read More
Kerri FitzgeraldOncology | April 25, 2023
The U.S. Food and Drug Administration (FDA) granted accelerated approval to Rubraca® (rucaparib) for the treatment of ...
Advertisement
Advertisement
Latest News

April 29, 2025